Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up, The Lancet, vol.384, pp.2027-2035, 2014. ,
,
Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer, N Engl J Med, vol.370, pp.932-942, 2014. ,
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer, N Engl J Med, vol.365, issue.2, pp.107-125, 2011. ,
Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer de la prostate, Prog En Urol, vol.27, issue.16, pp.30705-30714, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02297771
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent, Eur Urol, vol.71, pp.618-629, 2017. ,
Validation of a Nomogram Predicting the Probability of Lymph Node Invasion among Patients Undergoing Radical Prostatectomy and an Extended Pelvic Lymphadenectomy, Eur Urol, vol.49, pp.1019-1027, 2006. ,
Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores, Eur Urol, vol.61, pp.480-487, 2012. ,
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer, BJU Int, vol.114, pp.113-119, 2014. ,
Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer, Eur Urol, vol.61, pp.584-592, 2012. ,
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy, Eur Urol, vol.52, pp.29-37, 2007. ,
External validation of nomogram predicting the probability of specimen-confined disease (pT2-3a, R0N0) in patients undergoing radical prostatectomy and pelvic lymph node dissection, Urol Int, vol.93, pp.262-268, 2014. ,
Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation, Urol Oncol, vol.33, issue.9, pp.384-385, 2015. ,
External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy, J Endourol, vol.28, pp.416-423, 2014. ,
External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection, Urol Int, vol.90, pp.277-282, 2013. ,
,
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection, The Prostate, vol.73, pp.211-218, 2013. ,
,
Comparative Effectiveness of Robot-Assisted and Open Radical Prostatectomy in the Postdissemination Era, J Clin Oncol, vol.32, pp.1419-1426, 2014. ,
High Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Counts, J Natl Compr Canc Netw, vol.16, pp.395-401, 2018. ,
Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy, BJU Int, vol.107, pp.220-225, 2011. ,
External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients, The Prostate, vol.77, pp.928-933, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01906190
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era, Cancer, vol.95, pp.281-286, 2002. ,